CLINICAL_TRIALS
trial_result
· 2012-05-08
Clinical Trial Update: Glizigen-Viudid-External Anogenital Warts in Children and Adolescents [Phase 3]
Summary
A Phase 3 trial of Glizigen-Viudid for external anogenital warts in children and adolescents has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Catalysis SL | Conditions: External Anogenital Warts | Phase 3 | Status: COMPLETED